Imagin Medical(OTC) IMEXF

Market CapN/A

Since IPO (2016)-100%

5 Year-100%

1 Year+0%

1 Month+0%

$0.00

+0.00%

+0.00Today

Imagin Medical last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-14

Imagin Medical stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-06-29
1 month	+0%	USD 0.00	2026-06-29
3 month	+0%	USD 0.00	2026-04-30
Year to date	+0%	USD 0.00	2025-12-30
1 year	+0%	USD 0.00	2025-01-27
3 year	-100%	USD 0.08	2023-08-14
5 year	-100%	USD 0.34	2021-08-13
Since inception	-100%	USD 3.51	2016-03-07

Imagin Medical Financials at a Glance

Market Cap

N/A

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$3.32M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-1.32 (Low)

Dividend

$0.00

Beta (Volatility)

-1.32 (Low)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jun 27, 2024

Dividend

$0.00

Beta (Volatility)

-1.32 (Low)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jun 27, 2024

IMEXF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Imagin Medical

Imagin Medical Inc. is a urologic oncology company focused on the research, development, and commercialization of innovative medical devices. Headquartered in Vancouver, Canada, the company aims to enhance patient outcomes through advanced imaging technologies.

Products and Services

Medical imaging device for urologic applications
Research and development in bio-chemistry medical devices
Collaboration with Lawrence Livermore National Security, LLC

Growth Outlook

Recent quarterly net income of CAD 2,202,049 indicates potential profitability
Partnerships may enhance product development and market reach
Focus on innovative solutions positions the company for future growth

Financial Highlights

Trailing twelve months (TTM) revenue of CAD 0 reflects early-stage development
Current ratio of 0.0126 suggests liquidity challenges
Net income for Q3 2023 shows a significant turnaround from previous losses

AI Generated • Aug 8, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

E. James Hutchens

Website

www.imaginmedical.com

Headquarters

Vancouver, BC V6C 1L9, CA

IMEXF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

20.04%

Return on Capital

-2823.42%

Return on Assets

-184.48%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

Avg. Volume

54.921

Financials (TTM)

Gross Profit

-CA$163.17K

Operating Income

-CA$2.37M

EBITDA

-CA$5.70M

Operating Cash Flow

-CA$1.01M

Capital Expenditure

-CA$773.80K

Free Cash Flow

-CA$1.78M

Cash & ST Invst.

CA$22.17K

Total Debt

CA$10.98M

Imagin Medical Performance Analysis

Imagin Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-09-30	CAD 0	N/A
2022	2022-09-30	CAD 0	N/A

Imagin Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-09-30	N/A
Q1	2022-12-31	N/A
Q2	2023-03-31	N/A
Q3	2023-06-30	N/A

Imagin Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-09-30	CAD -1.00	N/A
2022	2022-09-30	CAD -0.20	-80.5%

Imagin Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-09-30	-193.5%
Q1	2022-12-31	100.3%
Q2	2023-03-31	-5473.3%
Q3	2023-06-30	348.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$46.33K

-505.6%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

CA$2.20M

-52.6%

EBITDA

-CA$293.00K

-106.3%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Total Cash

CA$22.17K

-84.8%

Total Debt

CA$10.98M

+22.7%

Accounts Receivable

CA$0.00

N/A

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$10.98M

+22.7%

Return on Assets

-1.84%

N/A

Return on Invested Capital

25.51%

N/A

Free Cash Flow

CA$17.60K

+102.6%

Operating Cash Flow

CA$17.60K

+102.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SONXSonendo, Inc.

SONXSonendo, Inc.$0.55-43.23%

EVARFLombard Medical, Inc.

EVARFLombard Medical, Inc.$0.00+0.00%

NVOSNovo Integrated Sciences, Inc.

NVOSNovo Integrated Sciences, Inc.$0.00+0.00%

NXENNexien BioPharma, Inc.

NXENNexien BioPharma, Inc.$0.00+0.00%

GBLXGB Sciences, Inc.

GBLXGB Sciences, Inc.$0.00+33.33%

ACGIThe Amacore Group, Inc.

ACGIThe Amacore Group, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NUNu Holdings

NUNu Holdings$15.23+0.09%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.76+0.01%

ONDSOndas

ONDSOndas$9.24+0.04%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$140.00-0.01%

INTCIntel

INTCIntel$102.50-0.02%

NVDANvidia

NVDANvidia$225.16-0.00%

NOKNokia

NOKNokia$10.76+0.02%

Questions About IMEXF

What is the current price of Imagin Medical?

Imagin Medical is trading at $0.00 per share.

What is the 52-week range for Imagin Medical?

Over the past 52 weeks, Imagin Medical has traded between $0.00 and $0.00.

How much debt does Imagin Medical have?

As of the most recent reporting period, Imagin Medical reported total debt of CA$9.55M.

How much cash does Imagin Medical have on hand?

Imagin Medical reported CA$29.35K in cash and cash equivalents in its most recent financial results.

What is Imagin Medical’s dividend yield?

Imagin Medical does not currently have a dividend yield.

Imagin Medical(OTC) IMEXF

Imagin Medical Financials at a Glance

IMEXF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Imagin Medical

IMEXF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Imagin Medical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMEXF

What is the current price of Imagin Medical?

What is the 52-week range for Imagin Medical?

How much debt does Imagin Medical have?

How much cash does Imagin Medical have on hand?

What is Imagin Medical’s dividend yield?

Premium Investing Services